Changes in plasma cholesterol levels after hospitalization for acute coronary events?

Cardiology (Switzerland)

Volumn 87, Issue 3, 1996, Pages 194-199

  Brugada, Ramon ^a   Wenger, Nanette K ^a   Jacobson, Terry A ^a   Clark, W Scott ^a   Cotsonis, George ^a   Iglesias, Anna ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BYPASS GRAFT; FEMALE; FIBRINOLYTIC THERAPY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHOLESTEROL; CORONARY ARTERY BYPASS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0029918398     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177086     Document Type: Article

References (22)

1. Watson WC, Buchanan KD. Dickson C: Senim cholesterol levels after myocardial infarction. Br Med J 1963;2:709-712.
2. Logan RW. Murdoch WR: Blood levels of hydrocortisone. Transaminases and cholesterol after myocardial infarction. Lancet 1966: ii: 521-524.
3. Fyfe T. Cochran KM. Baxter RH, Booth EM: Plasma-lipid changes after myocardial infarction. Lancet 1971;ii;997-1001.
4. Sniderman AD. Teng B: Predictable changes in low density lipoprotein composition after acute myocardial infarction. Atherosclerosis 1977; 27:361-368.
5. Ballantync FC, Melville DA. McKenna JP. Morrison BA, Ballantyne D: Response of plasma lipoproteins and acute phase proteins to myocardial infarction. Clin Chim Acta 1979: 99:85-92.
6. Hendclberg D, Rubinstein A, Levtov O. Bems L. Werbin B. Tamir I: Serum lipids and lipoprotein concentrations during the acute phase of myocardial infarction. Atherosclerosis 1980; 35:433-437.
7. Gore JM. Goldberg RJ. Matsumoto AS. Castelli WP. McNamara PM. Dalen JE: Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol 1984;54:722-725.
8. Ryder REJ, Hayes TM. Mulligan IP, Kings-wood JC. Williams S. Owens DR: How soon after myocardial infarction should plasma lipid values be assessed? Br Med J 1984:289:1651-1653.
9. Jackson R. Scragg R. Marshall R. White H. O'Brien K. Small C: Changes in serum lipid concentrations during first 24 hours after myocardial infarction. Br Med J 1987:294:1588-1589.
10. Sewdarsen M. Vythilingum S. Jialal J. Nadar R: Plasma lipids can be reliably assessed within 24 hours after acute myocardial infarction. Postgrad Med J 1988;64:352-356.
11. Mainard F. Ozanne P. Madec Y: Variations in lipoproteins, hormones and blood glucose during the early acute phase of myocardial infarction. Atherosclerosis 1988:69:225-231.
12. Mainard F, Madec Y. Robinet N: Variations in the composition of low-and high-density lipoproteins during the acute phase of myocardial infarction. Clin Chem 1988:34:139-140.
13. Ahnve S. Angelin B. Edhag O. Bcrglund L: Early determination of serum lipids and apolipo-protcins in acute myocardial infarction: Possibility for immediate intervention. J Intern Med 1989;226:297-301.
14. Chamsi-Pasha P. Taylor RJ. McDowell D. Barnes PC: Plasma lipids: When to measure after myocardial infarction: BJCP 1989:43: 447-449.
15. Qiu S, Theroux P, Gencst J Jr. Solymoss BC, Robitaille D. Marcil M: Lipoprotein (a) blood levels in unstable angina pectoris, acute myocardial infarction, and after thrombolytic therapy. Am J Cardiol 1991:67:1175-1179.
16. Wong ND. Wilson PWF. Kannel WB: Scrum cholesterol as a prognostic factor after myocardial infarction: The Framingham study. Ann Intern Med 1991;115:687-693.
17. Rosenson RS: Myocardial injury: The acute phase response and lipoprotein metabolism. JACC 1993;22:933-940.
18. Landymore RW: Inaccuracy of scrum lipid measurements after open heart operations. Can J Cardiol 1991:7:24-25.
19. Montague T. Tsuvuki R. Burton J. Williams R. Dzavik V. Tco K: Prevention and regression of coronary atherosclerosis. Chest 1994; 105:718-726.
20. Superko HR, Krauss RM: Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management. Circulation 1994:90:1056-1069.
21. The Scandinavian Simvastatin Survival Study (4S). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994:344:1383-1389.
22. Leidig GA Jr. Pasternak RC. Horowitz G. Ginsburg GS: Effects of heparin and cardiac catheterization on scrum lipoprotein and triglyceride levels. Am J Cardiol 1994:74:47-52.